153 related articles for article (PubMed ID: 37580691)
21. Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value.
Satoh Y; Onishi H; Nambu A; Araki T
Radiology; 2014 Jan; 270(1):275-81. PubMed ID: 24029640
[TBL] [Abstract][Full Text] [Related]
22. Predicting recurrence of non-small cell lung cancer based on mean computed tomography value.
Tamura M; Matsumoto I; Tanaka Y; Saito D; Yoshida S; Takata M
J Cardiothorac Surg; 2021 May; 16(1):128. PubMed ID: 33980268
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases.
Huang SY; Shen SJ; Li XY
World J Surg Oncol; 2013 Oct; 11():252. PubMed ID: 24088577
[TBL] [Abstract][Full Text] [Related]
24. Utility of Volumetric Metabolic Parameters on Preoperative FDG PET/CT for Predicting Tumor Lymphovascular Invasion in Non-Small Cell Lung Cancer.
Li C; Tian Y; Shen Y; Wen B; He Y
AJR Am J Roentgenol; 2021 Dec; 217(6):1433-1443. PubMed ID: 33978465
[No Abstract] [Full Text] [Related]
25. The prognostic impact of tumor volume on stage I non-small cell lung cancer.
Su XD; Xie HJ; Liu QW; Mo YX; Long H; Rong TH
Lung Cancer; 2017 Feb; 104():91-97. PubMed ID: 28213008
[TBL] [Abstract][Full Text] [Related]
26. Consistency and prognostic value of preoperative staging and postoperative pathological staging using
Kajiyama A; Ito K; Watanabe H; Mizumura S; Watanabe SI; Yatabe Y; Gomi T; Kusumoto M
Ann Nucl Med; 2022 Dec; 36(12):1059-1072. PubMed ID: 36264439
[TBL] [Abstract][Full Text] [Related]
27. Preoperative Patient and Lesion Features Are Valuable for Predicting the Prognosis of Resectable Peripheral Non-Small Cell Lung Cancer.
Qi LP; Li XT; Ma ZM; Yang Y; Chen JF; Sun YS
J Comput Assist Tomogr; 2022 Jul-Aug 01; 46(4):584-592. PubMed ID: 35405686
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of PET/CT uptake for peripheral clinical N0 non-small cell lung cancer.
Wang S; Lin D; Yang X; Zhan C; Zhao S; Luo R; Wang Q; Tan L
Cancer Med; 2020 Apr; 9(7):2445-2453. PubMed ID: 32056387
[TBL] [Abstract][Full Text] [Related]
29. Relationship and prognostic significance between preoperative serum albumin to globulin ratio and CT features of non-small cell lung cancer.
Guo X; Shao J; Zhai B; Zou Q; Yan J; Gu H; Wang G
Eur J Radiol; 2020 Jul; 128():109039. PubMed ID: 32417713
[TBL] [Abstract][Full Text] [Related]
30. Combining PD-L1 Expression and Standardized Uptake Values in FDG-PET/CT Can Predict Prognosis in Patients With Resectable Non-Small-Cell Lung Cancer.
Miyazawa T; Otsubo K; Sakai H; Kimura H; Chosokabe M; Morikawa K; Furuya N; Marushima H; Kojima K; Mineshita M; Koike J; Saji H
Cancer Control; 2021; 28():10732748211038314. PubMed ID: 34384268
[TBL] [Abstract][Full Text] [Related]
31. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
Hsu WH; Huang CS; Hsu HS; Huang WJ; Lee HC; Huang BS; Huang MH
Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963
[TBL] [Abstract][Full Text] [Related]
32. Correlation between FDG-PET/CT findings and solid type non-small cell cancer prognostic factors: are there differences between adenocarcinoma and squamous cell carcinoma?
Ito R; Iwano S; Kishimoto M; Ito S; Kato K; Naganawa S
Ann Nucl Med; 2015 Dec; 29(10):897-905. PubMed ID: 26342592
[TBL] [Abstract][Full Text] [Related]
33. Does FDG PET/CT have a role in determining adjuvant chemotherapy in surgical margin-negative stage IA non-small cell lung cancer patients?
Park HL; Yoo IR; Boo SH; Park SY; Park JK; Sung SW; Moon SW
J Cancer Res Clin Oncol; 2019 Apr; 145(4):1021-1026. PubMed ID: 30756189
[TBL] [Abstract][Full Text] [Related]
34. Metabolic tumor volume derived from
Ding C; Mao X; Li N; Huang M; Huang Z; Bao W; Li H; Fan J
Hell J Nucl Med; 2022; 25(1):63-70. PubMed ID: 35503557
[TBL] [Abstract][Full Text] [Related]
35. Tumor Volume Is Better Than Diameter for Predicting the Prognosis of Patients with Early-Stage Non-small Cell Lung Cancer.
Xie HJ; Zhang X; Mo YX; Long H; Rong TH; Su XD
Ann Surg Oncol; 2019 Aug; 26(8):2401-2408. PubMed ID: 31054041
[TBL] [Abstract][Full Text] [Related]
36. Long-term Observation of CT-guided Radiofrequency Ablation of Lung Neoplasm in 476 Consecutive Patients by a Thoracic Surgical Service: A Single-institutional Experience.
Huang BY; Zhou JJ; Yu ZQ; Song XY; Lin Y; Li XM; Li L
Acad Radiol; 2017 Dec; 24(12):1517-1525. PubMed ID: 28888381
[TBL] [Abstract][Full Text] [Related]
37. The prognostic significance of the 18F-fluorodeoxyglucose positron emission tomography/computed tomography in early-stage nonsmall cell lung cancer.
Geredeli C; Artac M; Kocak I; Koral L; Sakin A; Altinok T; Kaya B; Karaagac M
J Cancer Res Ther; 2020; 16(4):816-821. PubMed ID: 32930124
[TBL] [Abstract][Full Text] [Related]
38. Sarcomatoid Carcinoma of the Lung: The Mayo Clinic Experience in 127 Patients.
Maneenil K; Xue Z; Liu M; Boland J; Wu F; Stoddard SM; Molina J; Yang P
Clin Lung Cancer; 2018 May; 19(3):e323-e333. PubMed ID: 29454534
[TBL] [Abstract][Full Text] [Related]
39. Parameters of Dual-layer Spectral Detector CT Could be Used to Differentiate Non-Small Cell Lung Cancer from Small Cell Lung Cancer.
Mu R; Meng Z; Zhang X; Guo Z; Zheng W; Zhuang Z; Zhu X
Curr Med Imaging; 2022; 18(10):1070-1078. PubMed ID: 35260059
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer.
Kim K; Kim SJ; Kim IJ; Kim YS; Pak K; Kim H
Nucl Med Commun; 2012 Jun; 33(6):613-20. PubMed ID: 22407127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
